10. Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2020

Cited by (487)

Items 101–200 of 487

1. Effects of glucagon-like peptide-1 receptor agonists on liver-related and cardiovascular mortality in patients with type 2 diabetes
   Fu‐Shun Yen, Ming‐Chih Hou, James Cheng‐Chung Wei, Ying‐Hsiu Shih, Chii‐Min Hwu, Chih‐Cheng Hsu · 2024 · BMC Medicine
2. Cardiac Computed Tomography for Personalized Management of Patients With Type 2 Diabetes Mellitus
   Rhanderson N. Cardoso, Ramzi Dudum, Richard Ferraro, Márcio Sommer Bittencourt, Ron Blankstein, Michael Joseph Blaha, Khurram Nasir, Sanjay Rajagopalan, Erin D. Michos, Roger Scott Blumenthal et al. · 2020 · Circulation Cardiovascular Imaging
3. Safety and Tolerability of the Potassium Binder Patiromer From a Global Pharmacovigilance Database Collected Over 4 Years Compared with Data from the Clinical Trial Program
   Patrick Rossignol, Lea David, Christine S. Chan, Ansgar Conrad, Matthew R. Weir · 2021 · Drugs - Real World Outcomes
4. Risk factors, mortality trends, and cardiovascular diseases in people with Type 1 diabetes and controls in Sweden: An observational cohort study
   Sara Hallström, Magnus Olof Wijkman, Johnny Ludvigsson, Per Ekman, Marc Alan Pfeffer, Hans Wedel, Annika Rosengren, Marcus Lind · 2022 · The Lancet Regional Health - Europe
5. Positioning sulphonylureas in a modern treatment algorithm for patients with type 2 diabetes: Expert opinion from a European consensus panel
   Agostino Consoli, Leszek Czupryniak, Rui Duarte, György Jermendy, Alexandra Kautzky‐Willer, Chantal Mathieu, Miguel Melo, Ofri Mosenzon, Frank R. E. Nobels, Νικόλαος Παπάνας et al. · 2020 · Diabetes Obesity and Metabolism
6. Cardiometabolic medicine – the US perspective on a new subspecialty
   Cara Reiter–Brennan, Miguel Cainzos‐Achirica, Garshasb Soroosh, David R. Saxon, Michael Joseph Blaha, Robert H. Eckel · 2020 · Cardiovascular Endocrinology & Metabolism
7. GLP‐1 RA and atrial fibrillation in the cardiovascular outcome trials
   Zahra Hamedi, Basem M. Mishriky, Victor Okunrintemi, James R. Powell, Doyle M. Cummings · 2021 · Diabetes/Metabolism Research and Reviews
8. Efficacy and Safety of Adjunctive Cilostazol to Clopidogrel‐Treated Diabetic Patients With Symptomatic Lower Extremity Artery Disease in the Prevention of Ischemic Vascular Events
   Kallirroi Kalantzi, Nikolaοs Tentolouris, Andreas J. Melidonis, Styliani Papadaki, Michalis Peroulis, Konstantinos A. Amantos, George Andreopoulos, George Bellos, Dimitrios Boutel, Magdalini Bristianou et al. · 2020 · Journal of the American Heart Association
9. The Road to Approval: a Perspective on the Role of Icosapent Ethyl in Cardiovascular Risk Reduction
   Wang, Xiaowen, Verma, Subodh, Mason, R. Preston, Bhatt, Deepak L. · 2020 · Current Diabetes Reports
10. Quality assessment of videos on social media platforms related to gestational diabetes mellitus in China: A cross-section study
    Qin‐Yu Cai, Jing Tang, Si-Zhe Meng, Yi Sun, Xia Lan, Tai‐Hang Liu · 2024 · Heliyon
11. Impact of Expanded FDA Indication for Icosapent Ethyl On Enhanced Cardiovascular Residual Risk Reduction
    William E. Boden, Seth J. Baum, Peter Paul Toth, Sergio Fazio, Deepak L. Bhatt · 2020 · Future Cardiology
12. Henagliflozin monotherapy in patients with type 2 diabetes inadequately controlled on diet and exercise: A randomized, double‐blind, placebo‐controlled, phase 3 trial
    Juming Lu, Liujun Fu, Yan Li, Jianlin Geng, Li Qin, Ping Li, Hailong Zheng, Zilin Sun, Yanbing Li, Lihui Zhang et al. · 2021 · Diabetes Obesity and Metabolism
13. Cardiovascular risk profiles: A cross‐sectional study evaluating the generalizability of the glucagon‐like peptide‐1 receptor agonist cardiovascular outcome trials REWIND , LEADER and SUSTAIN ‐6 to the real‐world type 2 diabetes population in the United Kingdom
    Joanne Webb, Julie Mount, Lill‐Brith von Arx, Jonathan Rachman, Dionysis Spanopoulos, Robert P Wood, Theo Tritton, Olivia Massey, ISKANDAR RAUF IDRIS · 2021 · Diabetes Obesity and Metabolism
14. Type 2 Diabetes Mellitus–Related Mortality in the United States, 1999 to 2023
    Mushood Ahmed, Eeshal Zulfiqar, Aimen Shafiq, Maryam Shahzad, Tallal Mushtaq Hashmi, Raheel Ahmed, Jamal S. Rana, Stephen Sidney, Stephen John Greene, Robert John Mentz et al. · 2025 · JACC Advances
15. Group-Based Trajectory Modeling to Identify Patterns of Adherence and Its Predictors Among Older Adults on Angiotensin-Converting Enzyme Inhibitors (ACEIs)/Angiotensin Receptor Blockers (ARBs)
    R. Paranjpe, Michael L. Johnson, E. Essien, J. Barner, O. Serna, E. Gallardo, Z. Majd, M. Fleming, N. Ordonez, M. Holstad et al. · 2020 · Patient Preference and Adherence
16. Type 1 Diabetes and Aging
    Elena Toschi · 2023 · Endocrinology and Metabolism Clinics of North America
17. New Decade, New FDA Guidance for Diabetes Drug Development
    Enrico Giuseppe Ferro, Erin D. Michos, Deepak L. Bhatt, Abraham Michael Lincoff, Mohamed Badreldin Elshazly · 2020 · Journal of the American College of Cardiology
18. Blood pressure and cardiovascular diseases in Chinese adults with type 2 diabetes: A prospective cohort study
    Fiona Bragg, Jim Halsey, Canqing Yu, Hua Zhang, Ling Yang, Xiaohui Sun, Pei Pei, Yiping Chen, Huaidong Du, Canqing Yu et al. · 2021 · The Lancet Regional Health - Western Pacific
19. Macrovascular and microvascular outcomes of metabolic surgery versus GLP-1 receptor agonists in patients with diabetes and obesity
    Hamlet Gasoyan, Mohammad Hesam Alavi, Alexander Zajichek, Nicholas J. Casacchia, Abdullah Al Jabri, James Bena, Xiaoxi Feng, Rickesha L. Wilson, Ricard Corcelles, Winfield Scott Butsch et al. · 2025 · Nature Medicine
20. Role of Systemic Factors in Improving the Prognosis of Diabetic Retinal Disease and Predicting Response to Diabetic Retinopathy Treatment
    J. Mellor, Anita Jeyam, Joline W. J. Beulens, Sanjeeb Bhandari, Geoffrey Broadhead, Emily Y. Chew, Ward Fickweiler, Amber A. W. A. van der Heijden, Daniel Gordin, Rafael Simó et al. · 2024 · Ophthalmology Science
21. LDL-C/HDL-C ratio associated with carotid intima-media thickness and carotid plaques in male but not female patients with type 2 diabetes
    Rong Hui Du, Mingxia Li, Xi Wang, Suyuan Wang, Sheyu Li, Haoming Tian, Yunhong Wu, Chenghui Zhang · 2020 · Clinica Chimica Acta
22. Cardiovascular Risk/Disease in Type 2 Diabetes Mellitus
    Gabriela Román, Anca Pantea Stoian · 2021 · IntechOpen eBooks
23. The Prevalence of Cardiovascular Disease in Adults with Type 2 Diabetes in China: Results from the Cross-Sectional CAPTURE Study
    Tianpei Hong, Zongxun Yan, Li Li, Wei Tang, Lin Qi, Jianhua Ye, Jiangong Ren, Qin Wan, Wenhua Xiao, Di Zhao · 2022 · Diabetes Therapy
24. Sex and Age Differences in the Association Between Metabolic Dysfunction-Associated Fatty Liver Disease and Heart Failure: A Prospective Cohort Study
    Shouling Wu, Yuhao Li, Yijun Zhang, Xin Yu Su, Yingting Zuo, Guojuan Chen, Guozheng Xu, Shuohua Chen, Yan Ling He, Anxin Wang · 2024 · Circulation Heart Failure
25. Development and validation of 10‐year risk prediction models of cardiovascular disease in Chinese type 2 diabetes mellitus patients in primary care using interpretable machine learning‐based methods
    Weinan Dong, Eric Yuk Fai Wan, Dyt Fong, K. C. B. Tan, Wendy Wing Sze Tsui, Eric Ming‐Tung Hui, King Hong Chan, Colman Siu Cheung Fung, Cindy Lo Kuen Lam · 2024 · Diabetes Obesity and Metabolism
26. Decrease of coronary heart disease risk with GLP1-receptor agonists or SGLT2 inhibitors therapy in patients with type 2 diabetes in primary cardiovascular prevention: A 24 months follow-up study
    Luca D’Onofrio, Carmen Mignogna, Angela Carlone, Ermanno Bellizzi, Michela Guida, Chiara Moretti, Simona Zampetti, Gaetano Leto, Ernesto Maddaloni, Raffaella Buzzetti · 2021 · Diabetes Research and Clinical Practice
27. Management of LDL‐cholesterol levels in patients with Diabetes Mellitus in Cardiology Practice: Real‐life evidence of Under‐treatment from the EPHESUS registry
    Kadir Uğur Mert, Özcan Başaran, Gurbet Özge Mert, Volkan Doğan, İbrahim Rencüzoğulları, Bülent Özlek, Göksel Çinier, Utku Şenol, Oğuzhan Çelik, Eda Özlek et al. · 2021 · European Journal of Clinical Investigation
28. Aerobic Versus Resistance Training: Leptin and Metabolic Parameters Improvement in Type 2 Diabetes Obese Men
    Reza Rezaeeshirazi · 2021 · Research Quarterly for Exercise and Sport
29. Association of Impaired Fasting Glucose With Cardiovascular Disease in the Absence of Risk Factor
    Yingting Zuo, Xinsheng Han, Xue Tian, Shuohua Chen, Shouling Wu, Anxin Wang · 2021 · The Journal of Clinical Endocrinology & Metabolism
30. 2022 AHA/ACC Key Data Elements and Definitions for Cardiovascular and Noncardiovascular Complications of COVID-19: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards
    Biykem Bozkurt, Sandeep R. Das, Daniel Addison, Aakriti Gupta, Hani M. Jneid, Sadiya S. Khan, George Augustine Koromia, Prathit A. Kulkarni, Kathleen LaPoint, Eldrin Foster Lewis et al. · 2022 · Circulation Cardiovascular Quality and Outcomes
31. Polygenic risk score for ACE-inhibitor-associated cough based on the discovery of new genetic loci
    Jonas Ghouse, Vinicius Tragante, Ayesha Muhammad, Gustav Ahlberg, Morten Wagner Skov, Dan M. Roden, Ingileif Jónsdóttir, Laura Andreasen, Pia R. Lundegaard, Linea Christine Trudsø et al. · 2022 · European Heart Journal
32. Incidence of adverse cardiovascular events in type 2 diabetes mellitus patients after initiation of glucose‐lowering agents: A population‐based community study from the Shizuoka Kokuho database
    Shun Kohsaka, Hiraku Kumamaru, Shiori Nishimura, Satoshi Shoji, Eiji Nakatani, Nao Ichihara, Hiroyuki Yamamoto, Yoshiki Miyachi, Hiroaki Miyata · 2020 · Journal of Diabetes Investigation
33. EURASIAN ASSOCIATION OF CARDIOLOGY (EAC) GUIDELINES FOR THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES IN PATIENTS WITH DIABETES AND PREDIABETES (2021)
    Irina Evgen'evna Chazova, Marina Vladimirovna Shestakova, Yu. V. Zhernakova, Nataliya V. Blinova, Т. Н. Маркова, Natalya Valentinovna Mazurina, Ежов Марат Владиславович, Sergey N. Tereshchenko, И. В. Жиров, Andrey L. Komarov et al. · 2021 · Eurasian heart journal
34. Disparities in Use of Novel Diabetes Medications by Insurance: A Nationally Representative Cohort Study
    Bepo, Lurit, Nguyen, Oanh K., Makam, Anil N. · 2024 · Journal of General Internal Medicine
35. GLP ‐ 1RA and the risk of non‐arteritic anterior ischaemic optic neuropathy in patients with type 2 diabetes: A population‐based study
    Helen Tesfaye, Julie M. Paik, Deborah J. Wexler, Jimena Tatiana Carreno-Galeano, Elaine Wei-Yin Yu, Ariel Freedman, Joseph F. Rizzo, Elisabetta Patorno · 2025 · Diabetes Obesity and Metabolism
36. Цукровий діабет і артеріальна гіпертензія
    В. О. Сергієнко, O. Serhiyenko · 2021 · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine)
37. Human cell-based anti-inflammatory effects of rosiglitazone
    Mariangela Sottili, Tiziana Filardi, Giulia Cantini, Lorenzo Cosmi, Susanna Morano, Michaela Luconi, Andrea Lenzi, Clara Crescioli · 2021 · Journal of Endocrinological Investigation
38. Prevalence of Atherosclerotic Cardiovascular Disease, Heart Failure, and Chronic Kidney Disease in Patients with Type 2 Diabetes Mellitus: A Primary Care Research Network-based Study
    Geert Goderis, Bert Vaes, Pavlos Mamouris, Eline Van Craeyveld, Chantal Mathieu · 2021 · Experimental and Clinical Endocrinology & Diabetes
39. Age-specific prevalence, subtypes and risk factors of metabolic diseases in Chinese adults and the different patterns from other racial/ethnic populations
    Qiuyu Cao, Ruizhi Zheng, Ruixin He, Tiange Wang, Min Xu, Jieli Lu, Meng Dai, Di Zhang, Yuhong Chen, Zhiyun Zhao et al. · 2022 · BMC Public Health
40. New Approaches for the Prevention and Treatment of Cardiovascular Disease: Focus on Lipoproteins and Inflammation
    Aliza Hussain, Christie Mitchell Ballantyne · 2020 · Annual Review of Medicine
41. The prevention of gestational diabetes mellitus (The role of lifestyle): a meta-analysis
    Altemani, Abdullah H., Alzaheb, Riyadh A. · 2022 · Diabetology & Metabolic Syndrome
42. Beneficial effects of glucagon-like peptide 1 receptor agonists on glucose control, cardiovascular risk profile, and non-alcoholic fatty liver disease. An expert opinion of the Italian diabetes society
    Raffaele Napoli, Angelo Avogaro, Gloria Formoso, Salvatore Piro, Francesco Purrello, Giovanni Targher, Agostino Consoli · 2021 · Nutrition Metabolism and Cardiovascular Diseases
43. Long-Term Glycemic Variability and Risk of Cardiovascular Events in Type 2 Diabetes: A Meta-Analysis
    Ting Wang, Xin Zhang, Jian Liu · 2022 · Hormone and Metabolic Research
44. Postprandial hyperlipidemia as a risk factor in patients with type 2 diabetes
    Brian Tomlinson, Paul Chan, Christopher Wai Kei Lam · 2020 · Expert Review of Endocrinology & Metabolism
45. Ten things to know about ten cardiovascular disease risk factors (“ASPC Top Ten – 2020”)
    Harold Edward Bays · 2020 · American Journal of Preventive Cardiology
46. Trends in Total and Out-of-pocket Payments for Noninsulin Glucose-Lowering Drugs Among U.S. Adults With Large-Employer Private Health Insurance From 2005 to 2018
    Hui Shao, Michael Laxy, Stephen R. Benoit, Yiling J. Cheng, Edward W. Gregg, Ping Zhang · 2021 · Diabetes Care
47. Primary Barriers of Adherence to a Structured Nutritional Intervention in Patients with Dyslipidemia
    Fabiola Mabel Del Razo-Olvera, Angélica J. Martin-Vences, Griselda X. Brito-Córdova, Daniel Elías-López, María Victoria Landa-Anell, Marco Antonio Melgarejo-Hernández, Ivette Cruz‐Bautista, Iliana Manjarrez-Martínez, Donají Gómez‐Velasco, Carlos Alberto Aguilar-Salinas · 2021 · Nutrients
48. Myocardial Infarction and Coronary Artery Disease in Menopausal Women With Type 2 Diabetes Mellitus Negatively Correlate With Total Serum Bile Acids
    Xunxun Feng, Guangyao Zhai, Jiaqi Yang, Yang Liu, Yujie Zhou, Qianyun Guo · 2021 · Frontiers in Endocrinology
49. 2022 AHA/ACC Key Data Elements and Definitions for Cardiovascular and Noncardiovascular Complications of COVID-19
    Biykem Bozkurt, Sandeep R. Das, Daniel Addison, Aakriti Gupta, Hani M. Jneid, Sadiya S. Khan, George Augustine Koromia, Prathit A. Kulkarni, Kathleen LaPoint, Eldrin Foster Lewis et al. · 2022 · Journal of the American College of Cardiology
50. Nonalcoholic fatty liver disease and diabetes
    Maria Irene Bellini, Irene Urciuoli, Giovanni Del Gaudio, Giorgia Polti, Giovanni Iannetti, Elena Gangitano, Eleonora Lori, Carla Lubrano, Vito Cantisani, Salvatore Sorrenti et al. · 2022 · World Journal of Diabetes
51. Longitudinal association of electrocardiogram abnormalities with major adverse cardiac events in people with Type 2 diabetes: the Hoorn Diabetes Care System cohort
    Peter P. Harms, Petra J. M. Elders, Femke Rutters, Birgit Ilja Lissenberg-Witte, Hanno L. Tan, Joline W. J. Beulens, Giel Nijpels, Amber A. W. A. van der Heijden, for ESCAPE-NET · 2023 · European Journal of Preventive Cardiology
52. Efficacy and safety of patient-led versus physician-led titration of basal insulin in patients with uncontrolled type 2 diabetes: a meta-analysis of randomized controlled trials
    Marco Castellana, Filippo Procino, Rodolfo Sardone, Pierpaolo Trimboli, Gianluigi Giannelli · 2020 · BMJ Open Diabetes Research & Care
53. Use of the ankle-brachial index combined with the percentage of mean arterial pressure at the ankle to improve prediction of all-cause mortality in type 2 diabetes mellitus: an observational study
    Yu‐Hsuan Li, Wayne Huey‐Herng Sheu, I‐Te Lee · 2020 · Cardiovascular Diabetology
54. Rates and risk factors for amputation in people with diabetes in Japan: a historical cohort study using a nationwide claims database
    M. Kaneko, K. Fujihara, M. Harada, T. Osawa, Masahiko Yamamoto, Masaru Kitazawa, Y. Matsubayashi, T. Yamada, H. Seida, S. Kodama et al. · 2021 · Journal of Foot and Ankle Research
55. Long-term glycemic variability and risk of stroke in patients with diabetes: a meta-analysis
    Xiaoli Ren, Zhiyun Wang, Congfang Guo · 2022 · Diabetology & Metabolic Syndrome
56. Cardiovascular risk management in type 1 diabetes
    Teoh, I. H., Elisaus, P., Schofield, J. D. · 2021 · Current Diabetes Reports
57. Associations between Oral Glucose-Lowering Agents and Increased Risk for Life-Threatening Arrhythmias in Patients with Type 2 Diabetes Mellitus—A Literature Review
    Cristina Tudoran, Mariana Tudoran, Cătălina Giurgi-Oncu, Ahmed Abu-Awwad, Simona-Alina Abu-Awwad, Florica Voiţă-Mekereş · 2023 · Medicina
58. Real-world Analyses of Patients With Elevated Atherosclerotic Cardiovascular Disease Risk From the Optum Research Database
    Peter Paul Toth, MICHAEL L. HULL, Craig B. Granowitz, Sephy Philip · 2020 · Future Cardiology
59. Nondipping Blood Pressure: Predictive or Reactive Failure of Renal Sodium Handling?
    Jessica Ruth Ivy, Matthew A. Bailey · 2020 · Physiology
60. Serum superoxide dismutase activity: a sensitive, convenient, and economical indicator associated with the prevalence of chronic type 2 diabetic complications, especially in men
    Zhaoliang Fei, Wenxue Gao, Xiaojuan Xu, Hui Sheng, Shen Qu, Ran Cui · 2021 · Free Radical Research
61. Relative contributions of statin intensity, achieved low-density lipoprotein cholesterol level, and statin therapy duration to cardiovascular risk reduction in patients with type 2 diabetes: population based cohort study
    Ji Yoon Kim, Jimi Choi, Sin Gon Kim, Nam Hoon Kim · 2022 · Cardiovascular Diabetology
62. Sodium Glucose Cotransporter 2 Inhibitors, Amputation Risk, and Fracture Risk
    Clare Gabrielle Arnott, Robert A. Fletcher, Bruce Charles Neal · 2022 · Heart Failure Clinics
63. Long-Term Variability of Blood Pressure and Incidence of Heart Failure Among Individuals with Type 2 Diabetes
    Arnaud D. Kazé, Prasanna Santhanam, Sebhat A. Erqou, Alain Gerald Bertoni, Rexford S. Ahima, Justin Basile Echouffo-Tcheugui · 2021 · ESC Heart Failure
64. Injection-Site Nodules Associated With Once-Weekly Subcutaneous Administration of Semaglutide
    Elizabeth B. Hearn, Justin J. Sherman · 2020 · Diabetes Spectrum
65. Trends in high deductible health plan enrolment and spending among commercially insured members with and without chronic conditions: a Natural Experiment for Translation in Diabetes (NEXT-D2) Study
    Laura Faden Garabedian, Fang Zhang, Robert F. LeCates, Jamie Wallace, Dennis Ross‐Degnan, James Frank Wharam · 2021 · BMJ Open
66. Polygonatum sibiricum (Huang Jing) polysaccharide reduces diabetic cardiomyopathy through increasing cyclic guanosine monophosphate‐protein kinase G signaling in diabetic mice
    Shengping Lei, Xin Lu, Lei Yan, Tian Liu, Yan Niu, Jun Yu · 2024 · Journal of Diabetes Investigation
67. Practical guidance for use of oral semaglutide in primary care: a narrative review
    Javier Morales, Jay H. Shubrook, NEIL SKOLNIK · 2020 · Postgraduate Medicine
68. Aspirin for primary prevention of cardiovascular disease: a review of recent literature and updated guideline recommendations
    Amanda Mogul, Emily E. Leppien, Elizabeth Laughlin, Sarah A. Spinler · 2020 · Expert Opinion on Pharmacotherapy
69. Baseline and Cumulative Blood Pressure in Predicting the Occurrence of Cardiovascular Events
    Yingting Zuo, Deqiang Zheng, Shuohua Chen, Xinghua Yang, Yuxiang Yan, Fen Liu, Xue Tian, Meiping Wang, Xin Su, Jing Wen et al. · 2021 · Frontiers in Cardiovascular Medicine
70. Real-world evaluation of insulin requirements after GLP1 agonist or SGLT2 inhibitor initiation and titration
    Jamie George, Alison M. Lobkovich, Joseph A. Nardolillo, Nada Farhat, Sarah Kolander, Emily Thomas · 2022 · American Journal of Health-System Pharmacy
71. CVD incidence and mortality among people with diabetes and/or hypertension: Results from the English longitudinal study of ageing
    Paola Zaninotto, Andrew Steptoe, Eun‐Jung Shim · 2024 · PLoS ONE
72. Multifactorial analysis of risk factors for foot ulcers in patients with neurovascular complications of diabetes
    Zibo Fan, Jinyan Huang, Yue Liu, Hao Xie, Qinfeng Yang, Yue Liang, Hong Ding · 2024 · Frontiers in Endocrinology
73. Cardiovascular outcomes trials with glucagon‐like peptide‐1 receptor agonists: A comparison of study designs, populations and results
    Kevin M. Pantalone, Kashif M. Munir, Clinton M. Hasenour, Charles Messan Atisso, Oralee J. Varnado, Juan M. Maldonado, Маниге Кониг · 2020 · Diabetes Obesity and Metabolism
74. Managing the multifaceted nature of type 2 diabetes using once‐weekly injectable GLP‐1 receptor agonist therapy
    Andrew S. Bzowyckyj · 2020 · Journal of Clinical Pharmacy and Therapeutics
75. Blood Pressure Variability and Risk of Atrial Fibrillation in Adults With Type 2 Diabetes
    Arnaud D. Kazé, M. Yuyun, G. Fonarow, J. Echouffo-Tcheugui · 2023 · JACC: Advances
76. Evaluation of a Pharmacist-Led Intervention to Improve Statin Use in Persons with Diabetes
    Sarah L. Anderson, Joel C. Marrs, Cynthia R. Chachas, Brian S. Cichon, Amber D. Cizmic, Bianca B. Calderon, Tara Behring Vlasimsky · 2020 · Journal of Managed Care & Specialty Pharmacy
77. Standardized Hybrid Closed-Loop System Reporting
    Viral N. Shah, Satish K. Garg · 2020 · Diabetes Technology & Therapeutics
78. Long-Term Variability of Blood Pressure, Cardiovascular Outcomes, and Mortality: The Look AHEAD Study
    Arnaud D. Kazé, Prasanna Santhanam, Sebhat A. Erqou, Matthew Fomonyuy Yuyun, Alain Gerald Bertoni, Rexford S. Ahima, Justin Basile Echouffo-Tcheugui · 2021 · American Journal of Hypertension
79. The association of low‐density lipoprotein cholesterol with elevated arterial stiffness in adolescents and young adults with type 1 and type 2 diabetes: The SEARCH for Diabetes in Youth study
    Evgenia Gourgari, Jeanette M. Stafford, Ralph D'Agostino, Lawrence M. Dolan, Jean M. Lawrence, Santica M. Marcovina, Lina Merjaneh, Amy K. Mottl, AMY SANGHAVI SHAH, Dana Dabelea · 2020 · Pediatric Diabetes
80. Real-world national trends and socio-economic factors preference of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in China
    Cao Li, Shanshan Guo, Jiping Huo, Yiming Gao, Yilong Yan, Zhigang Zhao · 2022 · Frontiers in Endocrinology
81. Prediction of microvascular complications in diabetic patients without obstructive coronary stenosis based on peri-coronary adipose tissue attenuation model
    Yarong Yu, Xiaoying Ding, Lihua Yu, Ziting Lan, Yufan Wang, Jiayin Zhang · 2022 · European Radiology
82. Effectiveness of Incentives for Improving Diabetes-Related Health Indicators in Chronic Disease Lifestyle Modification Programs: a Systematic Review and Meta-Analysis
    LaShonda R. Hulbert, Shannon L. Michael, Jasmine Charter-Harris, Charisma Y. Atkins, Renée A. Skeete, Michael J. Cannon · 2022 · Preventing Chronic Disease
83. Metformin modulates the gut microbiome in a mice model of high-fat diet-induced glycolipid metabolism disorder
    Haoran Wu, Xinmiao Wang, Xinyi Fang, Fengmei Lian, Min Li, Jiangquan Liao, Dan Dai, Jiaxing Tian · 2022 · BMJ Open Diabetes Research & Care
84. Effects of Nondipping Blood Pressure Changes: A Nephrologist Prospect
    Elmukhtar M. Habas, Raza Ali Akbar, Gamal B. Alfitori, Khalifa L Farfar, Eshrak Habas, Nada Errayes, Aml Habas, Aisha Al Adab, Amnna Rayani, Nagat Geryo et al. · 2023 · Cureus
85. Efectos del ejercicio aeróbico sobre los componentes del síndrome metabólico en adultos mayores con diabetes mellitus tipo 2: revisión sistemática y metaanálisis
    Mercedes Miranda-Tueros, Joshua Jimmy Rony Ramirez Peña, Miguel Cabanillas‐Lazo, José Paz‐Ibarra, Isabel Angélica Pinedo-Torres · 2024 · Revista Peruana de Medicina Experimental y Salud Pública
86. Metabolic and cardiovascular risks of hormone treatment for transgender individuals
    Nipun Lakshitha de Silva, Anastasia Dimakopoulou, Oliver Quinton, Channa Nalin Jayasena · 2024 · Best Practice & Research Clinical Endocrinology & Metabolism
87. Effects of anti-diabetes medications on cardiovascular and kidney outcomes in Asian patients with type 2 diabetes: a rapid evidence assessment and narrative synthesis
    Takashi Kadowaki, Fumiko Yamamoto, Yusuke Taneda, Yusuke Naito, Douglas Clark, Søren Søgaard Lund, Tomoo Okamura, Kohei Kaku · 2021 · Expert Opinion on Drug Safety
88. Glycemic control is associated with dyslipidemia over time in youth with type 2 diabetes: The SEARCH for diabetes in youth study
    Ryan P. Brady, AMY SANGHAVI SHAH, Elizabeth T. Jensen, Jeanette M. Stafford, Ralph B. D'Agostino, Lawrence M. Dolan, Lisa Knight, Giuseppina Imperatore, Christine B. Turley, Angela D. Liese et al. · 2021 · Pediatric Diabetes
89. Chinese expert consensus on the risk assessment and management of panvascular disease inpatients with type 2 diabetes mellitus (2022 edition)
    Xi Chu, Bo Feng, Junbo Ge, Lixin Guo, Yong Huo, Linong Ji, Qian Jia, Song Jiang, Yong Li, Fang Liu et al. · 2022 · Cardiology Plus
90. Influence of Renin-Angiotensin System Inhibitors on Lower–Respiratory Tract Infections in Type 2 Diabetes: The Fremantle Diabetes Study Phase II
    Timothy M. E. Davis, Wendy Angela Davis · 2020 · Diabetes Care
91. Cardiovascular disease in patients with type 1 diabetes: Early evaluation, risk factors and possible relation with cardiac autoimmunity
    Mei Shi, Rong Tang, Fansu Huang, Ting Zhong, Yan Chen, Xia Li, Zhiguang Zhou · 2020 · Diabetes/Metabolism Research and Reviews
92. Pharmacokinetic Interaction Between Telmisartan and Rosuvastatin/Ezetimibe After Multiple Oral Administration in Healthy Subjects
    Chang Hee Kim, Sol Ip Kang, Dongseong Shin · 2020 · Advances in Therapy
93. High atherogenic risk concomitant with elevated HbA1c among persons with type 2 diabetes mellitus in North Ethiopia
    Hagos Amare Gebreyesus, Girmatsion Fisseha Abreha, Sintayehu Degu Besherae, Merhawit Atsbha Abera, Abraha Hailu, Aregawi Haileslassie Gidey, Afework Mulugeta, Tefera Belachew Lemma, Tsinuel Girma Nigatu · 2022 · PLoS ONE
94. Safety, pharmacokinetics and pharmacodynamics of Efsubaglutide Alfa in healthy participants: A randomised, dose‐escalation phase 1 study
    QINGHUA WANG, Qiaoli Cui, Yulong Xu, Gérald J. Prud’homme, Yuanxun Yang, Dalong Zhu, Yiming Li, Yehong Yang, Juan Li · 2025 · Diabetes Obesity and Metabolism
95. Diabetes modifies the association of prehypertension with cardiovascular disease and all‐cause mortality
    Yanlong Ren, Yingting Zuo, Anxin Wang, Shuohua Chen, Xue Tian, Haibin Li, Yan Ling He, Shouling Wu, Changsheng Ma · 2021 · Journal of Clinical Hypertension
96. Susceptibility of Glutathione-S-Transferase Polymorphism to CVD Develo- pment in Type 2 Diabetes Mellitus - A Review
    Santhi Priya Sobha, Kesavarao Kumar Ebenezar · 2021 · Endocrine Metabolic & Immune Disorders - Drug Targets
97. Partial Clinical Remission Reduces Lipid-Based Cardiovascular Risk in Adult Patients With Type 1 Diabetes
    Benjamin Udoka Nwosu, Sadichchha Parajuli, Krish Khatri, Gabrielle Jasmin, Layana Al‐Halbouni, Austin F. Lee · 2021 · Frontiers in Endocrinology
98. Fibroblast Growth Factor 21 Levels Exhibit the Association With Renal Outcomes in Subjects With Type 2 Diabetes Mellitus
    Li-Hsin Chang, Chia-Huei Chu, Chin‐Chou Huang, Liang‐Yu Lin · 2022 · Frontiers in Endocrinology
99. Statin‐induced autoimmune hepatitis in patients with type 1 diabetes: A report of two cases and literature review
    Eiji Kawasaki, Takahiro Fukuyama, Erisa Kuriyama, Aira Uchida, Yoko Sagara, Hidekazu Tamai, Yuko Nakano, Masayuki Tojikubo, Nobuhiko Koga · 2020 · Journal of Diabetes Investigation
100. How to Manage Hypertension in People With Diabetes
     Waleed Ali, George L. Bakris · 2020 · American Journal of Hypertension